Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression

Ductal carcinoma in situ (DCIS) will account for 62,930 cases of breast cancer in 2019. DCIS is a pre-invasive lesion which may not progress to invasive carcinoma, yet surgery remains the mainstay treatment. Molecular imaging of a specific marker for DCIS grade for detection and active surveillance...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachawal, Sunitha, Bean, Gregory R., Krings, Gregor, Wilson, Katheryne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190737/
https://www.ncbi.nlm.nih.gov/pubmed/32377564
http://dx.doi.org/10.1038/s41523-020-0158-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190737/
https://www.ncbi.nlm.nih.gov/pubmed/32377564
http://dx.doi.org/10.1038/s41523-020-0158-y

Ejemplares similares